Skip to content
Brasil Peru Mexico

 

  • ABRASCÃO 2025 Substance Use and Adherence to Oral PrEP Among MSM, Transvestites, and Transgender Women in Latin America: Results from the ImPrEP Study

  • ABRASCÃO 2025 Mental health and substance use among young people from sexual and gender minorities: findings from the ImPrEP CAB Brazil study

  • ABRASCÃO 2025 ImPrEP CAB Brazil: Analyzing PrEP Choices and Increasing Coverage of Prophylaxis with Injectable Cabotegravir in Key Young Populations

  • High syphilis incidence among PrEP – adherent men who have sex with men and transgender women in Peru

Imprep
Rio de Janeiro: Fundação Oswaldo Cruz – Fiocruz Av. Brasil, 4365 - Rio de Janeiro
9090 (21) 2260-6700 e (21) 3865-9659
imprep.bra@gmail.com
  • Home
  • What is PrEP?
  • IMPREP project
  • Sites that provide PrEP
  • Studies and Research
    • Presentations at Conferences
    • Published Articles

Category: Information

Information Knowledge Latest News

PREP AND OTHER PREVENTION STRATEGIES FOR USERS OF APPLICATIONS

In Brazil, as well as in other parts of the world, relationship applications have been the main platform for sexual…

5 de October de 2018
Information Knowledge News

MORE THAN 2,5 THOUSAND BRAZILIANS ALREADY USE PREP TO PREVENT HIV

The results of the first six months of implementation of the prophylaxis were presented during the World Conference on Aids…

5 de October de 2018
Information

DIVERSIFICATION OF PREP AND THE PREFERENCE FOR EACH METHOD

PrEP is not intended to be the only way of prevention to HIV, but one among other available options. The…

5 de October de 201818 de July de 2024
Information

AN OVERVIEW OF PREP IN SOME DEVELOPING COUNTRIES

The developing countries have specific characteristics that, in general, do not appear in studies with PrEP carried out in the…

5 de October de 201818 de July de 2024
Information

RESULTS OF PREP BRAZIL EVIDENCE THE SUCCESS OF PREP IN BRAZILIAN CONTEXT

Last month, PrEP Brazil’s team published an article on the magazine The Lancet HIV. The results of one year of PrEP…

5 de October de 201818 de July de 2024
Information News

Protocolo Clínico e Diretrizes Terapêuticas para Profilaxia Pré-Exposição (PrEP) de Risco à Infecção pelo HIV

Publicações: Protocolo Clínico e Diretrizes Terapêuticas, Assistência e Tratamento, PrEP (Assistência e Tratamento), Políticas de saúde, Medicamentos, Profissionais de Saúde HIV/Aids Última modificação: 21.12.2017 - 14:40…

26 de April de 201829 de May de 2018
Information

Truvada – One tablet per day

Truvada® is an antiretroviral drug approved by the Food and Drugs Administration (FDA), a body similar to the National Agency…

7 de March de 201829 de May de 2018
Information

Who can use PrEP?

Men who have sex with men (MSM), transvestites and transsexual women; Be 18 years of age or older; Not being…

7 de March de 201829 de May de 2018
Information

Frequently Asked Questions

What is PrEP? It is an acronym that comes from English, which means Pre-Exposure Prophylaxis. PrEP is the use of…

27 de February de 201829 de May de 2018

Posts navigation

Newer posts

Partners

UnitAid INI - Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Ministério da Saúde do Brasil UnitAid Universidad Peruana Cayetano Heredia Instituto Nacional de Salud Pública CONDESA Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Ministério da Saúde - Brasil
Theme of Rigorous Themes